再鼎医药（09688）今日盘中大涨5.34%，引起市场广泛关注。该股在早盘交易中表现突出，成为港股市场中的亮点之一。
消息面上，南向资金对再鼎医药的持续看好可能是推动股价上涨的主要因素。据悉，在4月14日，南向资金大幅增持再鼎医药474.18万股。截至当日收盘，港股通共持有再鼎医药1.8685亿股，占公司流通股的16.97%。这一举动显示出机构投资者对再鼎医药未来发展前景的信心增强。
值得注意的是，再鼎医药近期表现强劲。数据显示，该股在近5个交易日内累计上涨12.73%，期间港股通累计增持1678.81万股。然而，从更长期来看，再鼎医药在近20个交易日内下跌16.61%，但港股通仍然选择逆势增持，累计增持量达到3305.81万股。这种持续的增持行为可能反映了机构投资者对公司基本面的认可，也为今日的股价上涨提供了有力支撑。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.